Top compounds associated with response to OR2D2


Feature Type Standardized
Nominal ANOVA
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.0015 1
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0014 1
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0018 1
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.0016 1
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC 0.0016 1
mRNA BRD6340 CTRPv2 pan-cancer AAC -0.0015 1
mRNA BX-795 GDSC1000 pan-cancer AAC 0.0015 1
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.0016 1
mRNA XL765 CTRPv2 pan-cancer AAC -0.0015 1
mRNA BI-2536 GDSC1000 pan-cancer AAC 0.002 1
Download CSV